This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the Federal Government.

Official Name : Scott Gottlieb, M.D., Commissioner of Food and Drugs

Event Date : 01/30/2018 - 01/30/2018
Location : Silver Spring, MD
Subject : Opioid Policy Steering Committee Part 15 Hearing
FDA Participant/Group : THERESA TOIGO; PETER MARKS; ABIGAIL BRANDEL; GERALD DALPAN; RACHEL SHERMAN; SHARON HERTZ;
Non FDA Participant/Group : Healthcare professionals, academia, industry representatives, media and other registered guests

Event Date : 01/31/2018 - 01/31/2018
Location : Washington, DC
Subject : The National Association of State Departments of Agriculture Winter Policy Conference: Food Safety Modernization Act, State and Local Collaboration and Partnerships
FDA Participant/Group : SUSAN MAYNE; CAITLIN BOON; CATHERINE MCDERMOTT; MELINDA PLAISIER; JEFFREY FARRAR; STEPHEN OSTROFF; JENNIFER DOOREN;
Non FDA Participant/Group : State administrators of Departments of Agriculture staff, media, and other registered participants

Official Name : Rachel Sherman, M.D., M.P.H.,, Principal Deputy Commissioner

Event Date : 01/31/2018 - 01/31/2018
Location : NewYork, NY
Subject : Roundtable: The Future of Evidence Generation: Perspectives on Shifting FDA Focus in Real World Evidence (RWE)
FDA Participant/Group : N/A
Non FDA Participant/Group : Several members from ( McKinsey & Company);

Official Name : Anna Abram, Deputy Commissioner for Policy, Planning, Legislation, and Analysis

No Significant Event

Official Name : Mark Abdoo , Acting Deputy Commissioner for Global Regulatory Operations and Policy

No Significant Event

Official Name : Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name : Stephen M. Ostroff, M.D., Deputy Commissioner for Foods and Veterinary Medicine

No Significant Event

Official Name : Melinda Plaisier, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name : Mary Lou Valdez, M.S.M., Associate Commissioner for International Programs

No Significant Event

Official Name : Jennifer Rodriguez, Acting Associate Commissioner for External Affairs

No Significant Event

Official Name : RADM Denise Hinton , Acting Chief Scientist

No Significant Event

Official Name : Janet Woodcock, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name : Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

No Significant Event

Official Name : Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name : Susan T. Mayne Ph.D., Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name : Mitchell R. Zeller, J.D., Director, Center for Tobacco Products

No Significant Event

Official Name : Steven Solomon, Director, Center for Veterinary Medicine

Event Date : 01/30/2018 - 01/30/2018
Location : London, England
Subject : Veterinary Topics of Mutual Interest
FDA Participant/Group : MAI HUYNH; JONATHAN BRAY; LAURA HUFFMAN; MICHAEL OEHLSEN;
Non FDA Participant/Group : Brendan Cuddy, Esther Martinez, Sabine Haubenreisser, Spyridon Drosos (European Medicines Agency);

Official Name : William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research

Event Date : 02/02/2018 - 02/02/2018
Location : Jefferson, AR
Subject : Arkansas Research Alliance: Activity Plan Review 2018
FDA Participant/Group : N/A
Non FDA Participant/Group : Art Norris, Bryan Barnhouse, Jerry Adams (Arkansas Research Alliance);

Official Name : Rebecca K. Wood, J.D., Chief Counsel

No Significant Event